Active Ingredient
Docosanol 10%
The following Structured Product Label (SPL) was submitted to the FDA by Dolgencorp, Inc. (dollar General & Rexall) for the product Cold Sore Fever Blister Treatment (NDC 55910-550). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, do not use, when using this product, stop use and ask a doctor if, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Docosanol 10%
Cold sore/fever blister treatment
Allergy Alert: This product may cause a severe allergic reaction. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
For external use only
If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
benzyl alcohol, light mineral oil, propylene glycol, purified water, sucrose distearate, sucrose stearate
Call 1-888-309-9030
Compare to active ingredient of Abreva®†
Docosanol Cream, 10%
Cold sore/fever blister treatment
Portable convenient pump
NET WT 2 g (0.07 oz)
*Docosanol Cream, 10% contains the only OTC medicine approved by the FDA to shorten healing time and duration of symptoms.
†This product is not manufactured or distributed by GSK Consumer Healthcare, distributor of Abreva®.
RETAIN THIS INSERT FOR FULL PRODUCT USES, DIRECTIONS AND WARNINGS
DISTRIBUTED BY: OLD EAST MAIN CO.
100 MISSION RIDGE
GOODLETTSVILLE, TN 37072
* Please review the disclaimer below.